Coloplast A/S (CPH:COLO.B)
Denmark · Delayed Price · Currency is DKK 373.80
-6.20 (-1.63%)
Jun 17, 2026, 4:59 PM CET
Coloplast Market Cap
Coloplast has a market cap or net worth of 84.51 billion as of June 17, 2026. Its market cap has decreased by -41.18% in one year.
Market Cap
84.51B
Enterprise Value
107.67B
Revenue
28.05B
Ranking
n/a
PE Ratio
40.17
Stock Price
373.80
Market Cap Chart
Since November 17, 1997, Coloplast's market cap has increased from 5.88B to 84.51B, an increase of 1,337.16%. That is a compound annual growth rate of 9.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 17, 2026 | 84.51B | -31.38% |
| Dec 30, 2025 | 123.14B | -30.43% |
| Dec 30, 2024 | 177.00B | 2.05% |
| Dec 29, 2023 | 173.44B | 0.54% |
| Dec 30, 2022 | 172.51B | -29.57% |
| Dec 30, 2021 | 244.93B | 23.89% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.26T |
| Genmab | 100.56B |
| ALK-Abelló | 57.47B |
| Demant | 51.97B |
| H. Lundbeck | 40.66B |
| Zealand Pharma | 20.02B |
| Ambu A/S | 16.40B |
| Bavarian Nordic | 13.74B |